APP and Alzheimer disease: Their data showed that the resveratrol-loaded novel biomimetic nanosystem therapy improved the cognitive ability of APP/PS1 mice, decreased Aβ levels, mitigated brain inflammation, and improved mitochondrial oxidative stress in the hippocampi of AD mice [153].